Spire Wealth Management - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,526
+10.6%
2100.0%0.00%
Q2 2023$8,616
+14.8%
2100.0%0.00%
Q1 2023$7,505
+150000.0%
210
+68.0%
0.00%
Q4 2022$5
-99.9%
1250.0%0.00%
Q3 2022$6,000
-45.5%
125
-59.2%
0.00%
Q2 2022$11,000
-21.4%
306
-17.1%
0.00%
Q1 2022$14,000
-81.6%
369
-85.2%
0.00%
-100.0%
Q4 2021$76,000
+660.0%
2,490
+744.1%
0.00%
Q3 2021$10,000
-16.7%
2950.0%0.00%
Q2 2021$12,000
-88.9%
295
-88.2%
0.00%
-100.0%
Q1 2021$108,0002,5040.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders